A proportion of neural tube defects (NTDs) can be prevented by maternal folic acid supplementation, although some cases are unresponsive. The curly tail mutant mouse provides a model of folate-resistant NTDs, in which defects can be prevented by inositol therapy in early pregnancy. Hence, inositol represents a possible novel adjunct therapy to prevent human NTDs. The present study investigated the molecular mechanism by which inositol prevents mouse NTDs. Activation of protein kinase C (PKC) is known to be essential, and we examined neurulation-stage embryos for PKC expression and applied PKC inhibitors to curly tail embryos developing in culture. Although all known PKC isoforms were detected in the closing neural tube, use of chemical PKC inhibitors identified a particular requirement for 'conventional' PKC isoforms. Peptide inhibitors offer selective inhibition of individual PKCs, and we demonstrated isoform-specific inhibition of PKC in embryonic cell cultures. Application of peptide inhibitors to neurulation-stage embryos revealed an absolute dependence on the activity of PKCbI and c for prevention of NTDs by inositol, and partial dependence on PKCf, whereas other PKCs (a, bII d, and e) were dispensable. To investigate the cellular action of inositol and PKCs in NTD prevention, we examined cell proliferation in curly tail embryos. Defective proliferation of hindgut cells is a key component of the pathogenic sequence leading to NTDs in curly tail. Hindgut cell proliferation was stimulated specifically by inositol, an effect that required activation of PKCbI. Our findings reveal an essential role of specific PKC isoforms in mediating the prevention of mouse NTDs by inositol.
INTRODUCTION
Neural tube defects (NTDs) are common, severe birth defects with a multifactorial aetiology involving both genetic and environmental factors. In a proportion of cases, NTDs can be prevented by maternal peri-conceptional supplementation with folic acid (1, 2) . Around 30% of NTDs appear unresponsive to folic acid, however, and there is currently no preventive therapy available for these 'folate-resistant' defects. A large number of mouse genetic mutants exhibit NTDs and, as in humans, some of these are responsive to folic acid treatment whereas others are not (3, 4) . Mice homozygous for the curly tail mutation develop spina bifida that exhibits many similarities to the corresponding human NTD (5) . NTDs in curly tail mice are folate-resistant (6), but we showed that the majority of NTDs in curly tail mice can be prevented by both myo-inositol and its D-chiro-enantiomer, either administered to pregnant females or directly to embryos in vitro (7, 8) . Our findings raise the possibility of developing a novel clinical therapy based on inositol. The recent observation that inositol therapy is well tolerated during human pregnancy at high risk of NTD recurrence (9) , encourages progress towards a clinical trial of inositol.
The mechanism of action of inositol in preventing NTDs in curly tail mice involves activation of PKC, a family of serine/ threonine kinases (7) . The effect of inositol can be mimicked by brief treatment of embryos with TPA (12-O-tetradecanoylphorbol-13-acetate), an agonist of PKC. Moreover, the effect of inositol is blocked by co-administration of a broad-spectrum chemical inhibitor of PKC (7) . At least 10 isoforms of PKC are known, grouped according to their dependence on diacylglycerol (DAG) and Ca 2þ for activation (10) . Conventional PKCs (cPKCs; a, bI, bII, g) require DAG and Ca 2þ , novel PKCs (nPKCs; d, e, Z, y) are DAG-sensitive but Ca 2þ -insensitive, and atypical PKCs (aPKCs; z, l and the related PKCm) are activated by neither DAG or Ca 2þ (10) . To elucidate the molecular mechanism by which inositol normalizes neural tube closure, we determined which of the PKC isoforms mediate this effect. All known PKC isoforms could be detected during mouse neural tube closure, but culture of intact curly tail embryos in the presence of isoform-specific PKC inhibitors identified PKCbI and g as essential for the normalizing action of inositol. Other PKC isoforms were not required. At the cellular level, inositol treatment was found to correct the deficit of cell proliferation that underlies NTD development in curly tail embryos (11) , an effect that is blocked by inhibition of PKCbI. Moreover, treatment of cultured cells with either the PKC activator TPA or inositol itself, could induce translocation of PKC isoforms, including PKCbI and g to the nucleus. We conclude that PKCbI and g are essential components of the molecular mechanism underlying the preventive effect of inositol on mouse NTDs.
RESULTS

PKC isoform expression during mouse embryogenesis
In order to identify the isoforms that might play a role in prevention of NTD, we initially determined which PKC isoforms are expressed in mouse embryos undergoing organogenesis (E9.5 to E16.5). Western blot analysis of cytoplasmic (C), membrane-associated (Ps) and insoluble (Pi) fractions of embryonic cell extracts indicated the degree to which PKC isoforms are activated (i.e. associated with membrane or insoluble cellular compartments). All PKC isoforms could be detected, but their relative abundance varied with stage and cellular fraction (Fig. 1) . cPKCs (a, b, g) were weak or undetectable in the cytoplasmic fraction at E9.5 and E10.5, although expression increased from E11.5 onwards. Among the cPKCs, only PKCg was present in the Ps fraction from E11.5 and in the Pi fraction at the latest stages. nPKCs (d, e, y, Z) were expressed throughout the developmental period in both C and Ps fractions, whereas expression in the Pi fraction was more variable. aPKCs (l, z and the related PKCm) were abundant from E9.5 onwards in all cellular fractions, with a fairly constant level of expression. All PKC isoforms were also detected in mutant curly tail embryos with no consistent differences in abundance compared with non-mutant CD1 mice (data not shown). Hence, the DAG-responsive cPKCs and nPKCs, which are likely to mediate the normalizing effect of inositol (6) , exhibit evidence of stage-dependent activation unlike the aPKCs which appear ubiquitous and constitutively activated, as also described in other systems (12) .
Western blot analysis was insufficiently sensitive to detect PKC isoform expression in specific embryonic regions, such as the posterior neuropore (PNP), the site of spinal neurulation (13) . We performed immunohistochemistry on histological sections through the PNP region, and detected expression of PKCs a, bI, bII, g and e in the closing neural tube, hindgut, notochord and presomitic mesoderm, at both E9.5 and E10.5 ( Fig. 2) . We conclude that although cPKCs, in particular, are variably expressed in whole neurulation-stage embryos by immunoblotting, they can be detected in all tissues of the PNP region by immunohistochemistry and, therefore, are candidates for a role in mediating the preventive effect of inositol on NTDs. Immunostaining was not carried out for the remaining isoforms as they were clearly detectable by western blot (Fig. 1) .
Chemical PKC inhibitors block the protective effect of inositol on NTDs
We used PKC inhibitors to block the effect of inositol on neural tube closure. Curly tail embryos were cultured from E9.5 to E10.5, and the length of unclosed neural folds at the PNP was then measured to indicate predisposition to spina bifida (13) . Embryos exposed to PBS (vehicle) alone had enlarged PNPs (Fig. 3A) , reflecting the in vivo development of spinal NTDs by 50-60% of curly tail embryos (5), whereas treatment with myo-inositol decreased PNP length significantly (first grey bar, Fig. 3A) , to a value characteristic of normally developing embryos (5) . Hence, inositol normalizes PNP closure in vitro, confirming previous findings (7, 8) . Curly tail embryos were exposed in culture to chemical inhibitors that block different combinations of PKC isoforms. Bisindolylmaleimide I (BisI) inhibits PKCa, bI, bII, g and e (14), Go6976 inhibits solely cPKCs (15) , HBDDE inhibits PKCa and g in vitro (16) and LY294002 is an inhibitor of phosphatidylinositol-3-kinase (17) , an activator of PKCz (18) . When added alone, none of the inhibitors significantly altered PNP length (white bars, Fig. 3A) . Moreover, BisV, an inactive control, did not prevent the reduction in PNP length caused by co-administration of inositol (second grey bar, Fig. 3A ). In contrast, BisI, Go6976, HBDDE and LY294002 all partially blocked the normalizing effect of inositol, such that PNP length was reduced to a significantly lesser degree than in the presence of inositol alone (black bars, Fig. 3A) . Hence, use of chemical inhibitors highlights the Figure 1 . Developmental regulation of PKC isoform expression in mouse embryos from E9.5 to E16.5. Sub-cellular protein fractions of whole embryo homogenates were western blotted using isoform-specific anti-PKC antibodies. PKC isoforms exhibit varying patterns of developmental regulation ranging from limited expression in only the C fraction, at only the most advanced developmental stages (PKCa and b) to constitutive expression in all three fractions, throughout the developmental period studied (PKCZ, z, l and m). Abbreviations: A, b-actin control; C, cytoplasmic fraction; Co, Coomassie Blue stained loading control; MBr, mouse brain standard; Ps, soluble pelleted fraction (membrane associated); Pi, insoluble pelleted fraction. Experiment performed on two occasions with same result. Peptide inhibitors identify a critical role for PKCbI, c and f in the inositol effect
Because of the relatively broad spectrum activity of chemical PKC inhibitors, we next applied isoform-specific peptide PKC inhibitors to cultured curly tail embryos, to more precisely define the PKC isoform requirement for the inositol effect. Each peptide inhibitor was designed to the amino acid sequence corresponding to the isoform-specific RACK (receptor for activated C kinase) binding site on PKC. Inhibitors of this type prevent PKC translocation and/or activation in an isoform-specific manner (19, 20) . Peptide inhibitors were coupled to a sequence derived from the Drosophila Antennapedia homeodomain, ensuring cell permeability. As with the chemical inhibitors, peptide PKC inhibitors alone had no significant effect on PNP length. Moreover, Figure 2 . Ubiquitous expression of PKC isoforms during mouse spinal neurulation, detected by immunohistochemistry. Transverse histological sections through the posterior neuropore region of curly tail mouse embryos at E9.5 (A, D, G, J, M) and E10.5 (B, E, H, K, N) stained with antibodies specific for PKCa, bI, bII, g and e. All PKCs exhibit ubiquitous expression in the neural plate, notochord, hindgut and presomitic mesoderm of the posterior neuropore region. Sections of adult mouse cerebellum (C, F, I, L, O) provide a positive control for the isoform-specific PKC antibodies: anti-PKCa, g and e stain only Purkinje cells, whereas anti-PKCbI and bII stain only granule cells, as described previously for the rat cerebellum (46) . Abbreviations: G, granule cells; H, hindgut; M, presomitic mesoderm; N, notochord; Np, neural plate; P, Purkinje cells. Scale bar represents 20 mm. ) isoform-specific peptide PKC inhibitors were applied to curly tail mouse embryos cultured from E9.5 for 24 h, followed by measurement of posterior neuropore (PNP) length, an indicator of predisposition to spinal NTD (13) . White bars: PNP length of embryos exposed to PKC inhibitors in the absence of inositol; grey bars: PNP length of embryos exposed to PKC inhibitors in the presence of inositol; black bars: PNP length in the presence of PKC inhibitor plus inositol as a % of the value in the presence of PKC inhibitor alone (right axis). (A) Inositol significantly reduces PNP length in the absence of inhibitor (PBS; P < 0.001) and in the presence of inactive BisV (P < 0.002), whereas the inositol effect is abrogated in the presence of chemical inhibitors BisI, Go6976, HBDDE and LY294002 (P > 0.05). (B) Inositol significantly reduces PNP length in the absence of inhibitor (PBS; P < 0.001) and in the presence of inactive peptide (Pept) or peptide inhibitors to PKC a, bII, d (P < 0.005) and e (P < 0.05), whereas the inositol effect is abrogated by inhibitors to PKCbI, g and z (P > 0.05). There is no effect on PNP length of either chemical or peptide inhibitors in the absence of inositol (analysis of variance, P > 0.05).
Human Molecular Genetics, 2004, Vol. 13, No. 1 9 the normalizing effect of inositol on PNP length persisted in the presence of inhibitors for PKCa, bII, d and e, as well as an inactive peptide (Fig. 3B) . Strikingly, however, the co-addition with inositol of inhibitors for PKCbI or g largely abolished the normalizing effect of inositol (black bars in Fig. 3B ). Inhibition of PKCz also partially blocked the normalizing action of inositol. These findings are consistent with the results from use of the chemical inhibitors, and indicate that the cPKCs, bI and g, and additionally PKCz, are critical for mediating the preventive effect of inositol.
Activation of PKC isoforms in embryonic mouse cells is blocked by peptide inhibitors
One possible explanation for the apparently isoform-specific PKC requirement for inositol action is that bI, g and z are the only isoforms whose activation is blocked by peptide inhibitors in curly tail embryonic cells. To test this idea, primary fibroblastic cell cultures, prepared from caudal regions of E9.5 curly tail embryos were serum-starved, and then treated with the PKC agonist, TPA, in the presence or absence of peptide PKC inhibitors. Prior to TPA treatment, each PKC isoform exhibited cytoplasmic localization (Fig. 4A , D, G, J and M) but, following TPA treatment, all isoforms translocated to the nucleus (Fig. 4B , E, H, K and N), indicative of activation. In every case, addition of the appropriate peptide inhibitor blocked this TPA-induced translocation indicating that PKC activation had been prevented (Fig. 4C , F, I, L and O). Closely similar results were obtained with the mouse 3T3 cell line (data not shown).
In view of the close relationship between PKCbI and its alternatively spliced variant PKCbII, we tested whether abrogation of the inositol effect by the PKCbI inhibitor might have resulted from antagonism of both PKCbI and bII activation. PKCbI translocated to the nucleus following TPA stimulation, and this translocation was blocked by the bI inhibitor, but not by the bII inhibitor (Fig. 5A-C) . Conversely, translocation of PKCbII was blocked by the bII inhibitor but not the bI inhibitor (Fig. 5D-F) . This finding confirms that the peptide inhibitors of PKCbI and bII are indeed isoform-specific and suggests separate roles for these splice variants. We conclude that the requirement for specific PKC isoforms is unlikely to reflect differential activity of the peptide inhibitors, but may reflect a difference in participation of PKC isoforms in the action of inositol in preventing mouse NTDs.
To determine whether the PKC stimulation observed after TPA treatment also follows inositol administration, we studied PKC localization after inositol treatment. Inositol treatment was capable of inducing the translocation of PKCa from the cytoplasm, as in serum-starved cells, to the nucleus ( Fig. 5G  and H) . Similarly, PKCbI and g, isoforms whose activity is essential for prevention of NTD, were also found to exhibit nuclear localization in inositol-treated but not in untreated cells (data not shown). No difference in the localization of PKCz could be detected after 6 h inositol treatment (50 mg/ml), but we cannot rule out the possibility that PKCz is activated at a different dose or at a different time point. This observation suggests that PKCa, bI and g can be activated by inositol treatment. However, PKCa is not required for prevention of NTD whereas PKCbI and g are essential.
Embryonic cell proliferation is stimulated by inositol, in a PKCbI-sensitive manner Delayed closure of the PNP in curly tail embryos results from a reduced rate of cell proliferation, specifically in the embryonic hindgut, within the caudal region (3, 11, 21, 22) . The resulting proliferation imbalance causes ventral curvature of the caudal region, counteracting the apposition of the neural folds, and leading to spina bifida (23, 24) . The effect of inositol on cell proliferation was examined by immunohistochemistry for PCNA (proliferating cell nuclear antigen) and phospho-histone H3, markers of S-phase and M-phase of the cell cycle respectively. A significant stimulatory effect of inositol on Figure 4 . Inhibition of PKC isoform translocation by peptide inhibitors in TPAtreated mouse embryonic cells. Immunocytochemistry using isoform-specific antibodies to PKC (as in Fig. 2 ) in curly tail primary embryonic cell cultures. Cells cultured for 18 h in growth medium containing 1% FCS were either fixed with no additional treatment ('serum starved'; A, D, G, J, M), exposed to 100 mM TPA for 10 min prior to fixation (þTPA; B, E, H, K, N), or exposed to 1 mM isoform-specific PKC inhibitor for 20 min and to TPA for 10 min prior to fixation (TPA þ Inhib; C, F, I, L, O). PKCs are uniformly located in the cytoplasm of serum starved cells whereas a 10 min treatment with TPA induces translocation to the nucleus in all cases. Pre-treatment with isoform-specific PKC inhibitors prevents TPA-induced translocation and all PKC isoforms exhibit cytoplasmic staining. Inset in (O) shows same field stained with DAPI to demonstrate nuclei. Scale bar represents 20 mm.
the percentage of PCNA-positive (Fig. 6A ) and histone H3-positive (Fig. 6B ) cells was detected in the hindgut, whereas inositol treatment had no effect on either proliferation marker in the neuroepithelium or notochord (Fig. 6A and B) . Co-administration of the PKCbI peptide inhibitor blocked the stimulatory effect of inositol on hindgut proliferation, whereas the PKCe inhibitor had no effect. Neither inhibitor significantly altered proliferation in neuroepithelium or notochord. Hence, inositol overcomes the genetically-determined defect of cell proliferation in curly tail embryos, an effect that requires activation of PKCbI.
DISCUSSION
Inositol normalizes neural tube closure in the spinal region of curly tail mouse embryos destined to develop spina bifida (7), whereas folic acid has no preventive effect (6) . Brief treatment with the PKC agonist TPA mimics the inositol effect, whereas the PKC inhibitor BisI abrogates inositol-mediated prevention (7) . Here, we used other chemical PKC inhibitors, with reportedly narrower spectra of action, and showed that these are also able to block the inositol effect. However, the precise specificity of chemical PKC inhibitors may vary between cell types. For example, HBDDE is specific for PKCa and g in vitro (16), but acts on other molecular targets in cerebellar granule neurons (25) . This prompted the use of peptide PKC inhibitors which were able to block the translocation of specific PKC isoforms. Isoform-by-isoform analysis using these inhibitors revealed a requirement for PKCbI, g and z, but not other PKCs in the normalization of neural tube closure in curly tail embryos. Figure 5 . Inositol stimulates PKC translocation, whereas peptide inhibitors to PKCbI and bII exhibit isoform-specificity in blocking translocation. PKC isoforms were localized by immunocytochemistry on primary cell cultures established from curly tail mouse embryos. Serum starved cells exhibit PKCbI and bII immunoreactivity in the cytoplasm. TPA-induced translocation to the nucleus of PKCbI can be blocked by the bI inhibitor (C) but not by the bII inhibitor (B). Conversely, translocation to the nucleus of PKCbII can be blocked by the inhibitor to bII (E) but not by the inhibitor to bI (F). Addition of 50 mg/ml myo-inositol to serum starved cells 6 h prior to fixation induces translocation of PKCa to the nucleus (H) whereas PKCa is cytoplasmic in untreated cells (G). This effect of inositol is not unique to curly tail cells as similar results were obtained in 3T3 cells. Scale bar represents 20 mm. Figure 6 . Inositol stimulates hindgut cell proliferation during NTD prevention, an effect requiring activation of PKCbI but not PKCe. Cell proliferation was measured in tissues of the posterior neuropore region of cultured curly tail embryos by (A) PCNA labelling, a measure of cells in S-phase and (B) phospho-histone H3 labelling, a marker of mitotic cells. Cell proliferation is most rapid in neuroepithelium, less intense in hindgut endoderm and slowest in notochord, as described previously (11) . Inositol significantly stimulates PCNA labelling (P < 0.005) and histone H3 labelling (P < 0.02) in hindgut endoderm, whereas inositol has no significant effect on PCNA or histone H3 labelling in either neuroepithelium or notochord (P > 0.05). In hindgut endoderm, inhibition of PKCbI significantly reduces histone H3 labelling compared with inositol alone (P < 0.05), whereas inhibition of PKCe has no significant effect (P > 0.05). Blocking PKCbI or e has no significant effect on histone H3 labelling in neuroepithelium or notochord (P > 0.05). No cells were positive for histone H3 in the presence of inositol and the PKCbI inhibitor (Fig. 6B , notochord data, bar 5). Labelling indices are meanAE SEM of at least 10 embryos per treatment.
Developmental regulation of PKC isoform expression
We detected all PKC isoforms, during mouse development from E9.5 to E17.5, in agreement with previous analysis of PKCs in E15-17 fetuses (26) . Our findings contrast with a study of E10.5 embryos that detected PKCa, d and z, but not bI, bII, g and e (27) . This difference may reflect the low abundance of cPKCs on western blot, at early stages (E9.5-11.5) in particular, although all isoforms were clearly detectable in the PNP region by immunohistochemistry. Each PKC isoform exhibited a distinct distribution between sub-cellular fractions, which likely reflects the degree of activation. For instance, cPKCs were confined to the cytoplasmic fraction, suggesting minimal activation during undisturbed development, whereas aPKCs were present in membraneassociated and insoluble fractions throughout development, suggesting constitutive activation, as described in other systems (12) . This finding is consistent with a role for the cPKCs, bI and g, in mediating the preventive effect of inositol, since activation of these isoforms may be limiting in the absence of inositol, providing capacity for activation after treatment.
PKC isoforms and cell cycle regulation
We have demonstrated that inositol stimulates cell proliferation in the hindgut of curly tail embryos, reversing the imbalance of cell proliferation that is known to lead, via enhanced ventral curvature of the caudal region, to delay or failure of PNP closure (11, 23, 24, 28) . Moreover, PKCbI but not PKCe is required for this stimulation of cell proliferation. PKCbI has been previously associated with increased cell cycle entry. Its over-expression leads to increased proliferation of aortic endothelial cells, in contrast to PKCa which has an inhibitory effect (29) . Similarly, proliferation of vascular smooth muscle cells is stimulated by PKCbI, through increased S-phase entry, but inhibited by PKCbII, through extension of S-phase (30). S-phase entry/progression has been suggested to be defective in hindgut cells of curly tail embryos (11), raising the possibility that activation of PKCbI may reverse this defect, leading to 'rescue' of the mutant phenotype. Interestingly, inositol treatment of cells for 6 h resulted in nuclear translocation of PKCbI and g in some cells, as observed for short-term exposure to TPA. This nuclear localization suggests that a role of PKCbI in cell cycle regulation is plausible. PKCa also exhibits nuclear translocation in inositol-treated cells (both curly tail and non-mutant), but does not play an essential role in the prevention of NTD.
Molecular basis of the requirement for PKCf and PI3-kinase
The normalizing effect of inositol on PNP closure was partially blocked by inhibition of PKCz or PI3-kinase. The requirement for PKCz may reflect a role in regulating other PKC isoforms (31) . PKCz is activated downstream of PI3-kinase (18) , whose activity in turn depends on availability of phosphatidylinositol species. Hence, inositol administration may activate both PI3-kinase and PKCz, by increasing flux through intracellular phosphoinositide metabolism. Indeed, inhibition of the inositol phosphate cycle by lithium blocks the preventive effect of inositol (7) . The requirement for PI3-kinase may also be explained by its participation, with 3-phosphoinositidedependent protein kinase-1 (PDK1) (32) , in phosphorylation of the T-loop of the kinase domain, a requirement for activity of PKCs (33) . Although we detected nuclear translocation of PKCa, bI and g following treatment of cells with inositol for 6 h, altered localization of PKCz was not detected. This could be simply due to suboptimal dose or period of treatment (activation could be short-lived), but it is also likely that PKCz activation occurs by a different mechanism to the classical isoforms as PKCz is not diacylglycerol-responsive. Moreover, the partial requirement for PKCz in the protective effect of inositol may reflect a permissive role for PKCz activity that does not involve translocation to the nucleus.
Is PKC implicated in the mechanism of neural tube closure?
Several lines of evidence suggest that spinal neurulation per se does not depend on PKC activation and that defective closure in curly tail embryos is unlikely to result from an intrinsic deficiency in specific PKC isoforms. First, exposure of curly tail embryos to PKC inhibitors, in the absence of inositol, did not affect PNP closure. Similar findings were obtained with non-mutant CD1 embryos (data not shown). Second, there is no difference in abundance of PKC isoforms between affected and unaffected curly tail embryos (data not shown). Third, uptake and incorporation of 3 H-inositol occurs similarly in cultured curly tail and non-mutant embryos, while inositol deficiency in vitro does not increase the penetrance of spinal NTDs in curly tail embryos (7) . Finally, mice with targeted inactivation of the genes encoding PKCa, b, g, d, e and z do not exhibit neurulation defects (34) (35) (36) (37) (38) (39) . We suggest, therefore, that prevention of NTDs in curly tail mice by exogenous inositol operates via stimulation of the cell cycle in the embryonic hindgut, an effect that requires activation of specific PKC isoforms. Inositol is also reported to prevent NTDs in animal models of diabetes (40) , whereas inositol deficiency causes cranial NTD, even in non-mutant mice (41) . It remains to be determined whether the protective action of inositol also involves stimulation of cell proliferation in these cases.
MATERIALS AND METHODS
Mouse strains and embryo culture
Curly tail mice were maintained as described (5) . Non-mutant random-bred CD1 mice were purchased from Charles River, UK. Mice were paired overnight and females checked for copulation plugs the following morning, designated embryonic day (E) 0.5. Embryos were explanted at E9.5 and those with 17-19 somites were cultured for 24 h in rat serum (6) . Embryos were randomly allocated to treatment groups to minimize the effect of litter-to-litter variation. Cultures were supplemented with 1% (v/v) additions of phosphate buffered saline (PBS) or myo-inositol (50 mg/ml, final concentration). PKC inhibitors were added as 1% (v/v) additions. Bisindolylmaleimide (Bis) I and V, Go6976, HBDDE and LY294002 (all from Calbiochem) were diluted in minimal volumes of DMSO, further diluted in PBS, and added to cultures at final concentrations corresponding to their IC 50 values (14-17): 10 mM (BisI, BisV, Go6976), 50 mM (HBDDE) or 1.4 mM (LY294002). DMSO diluted in PBS was added to control cultures. Peptide PKC inhibitors (supplied by Dr D. Mochly-Rosen) were added to embryo cultures to final concentrations of 1 mM: PKCaC2-4, PKCbIV5-3, PKCbIIV5-3, PKCgC2-4, PKCdV1-1; PKCeV1-2 and PKCz (pseudosubstrate region) (19, (42) (43) (44) (45) ). An Antennapedia peptide dimer served as an inactive control.
Statistical analysis
Comparison of multiple experimental groups was carried out by one way analysis of variance or by Kruskal-Wallis test (for data that were not normally distributed). Where significant variation was detected, multiple pairwise comparisons were performed by Tukey t-test or by Dunn's test. A value of P < 0.05 was considered significant where the power of the test exceeded 0.8. Statistical tests were computed using SigmaStat 2.03 software.
Western blot of PKC isoforms
Embryos were homogenized in ice cold buffer (60 mM Tris/ HCl, pH 7.5, 0.25 M sucrose, 10 mM EGTA, 5 mM EDTA, 500 mM leupeptin, 1 mM PMSF, 0.1 U/ml aprotinin, 1 mM dithiothreitol, 100 mM sodium vanadate, 50 mM sodium fluoride) and prepared as sub-cellular fractions: centrifugation at 100 000g for 30 min yielded a supernatant (C fraction). The pellet was resuspended in homogenization buffer containing 1% Triton X-100, and spun at 40 000g for 15 min., yielding a second supernatant (Ps-fraction) and a pellet (Pi-fraction). Samples were western blotted with mouse monoclonal IgGs for specific PKC isoforms (Transduction Laboratories), diluted as: a, 1 : 1000; b, 1 : 250; g, 1 : 5000; d, 1 : 500; e, 1 : 1000; i/l, 1 : 250; m, 1 : 250; y, 1 : 250; z, 1 : 1000, or rabbit polyclonal anti-PKC Z (1 : 2000; Sigma). Constant protein loading was confirmed in parallel blots probed with rabbit anti-b-actin (1 : 5000; Sigma). Blots were exposed to horseradish peroxidase-linked rabbit secondary antibodies and visualized by ECL detection system (Amersham Bioscience). Positive controls were C-fraction from adult male CD1 mouse brain or spleen.
Immunohistochemistry E9.5-10.5 embryos were fixed in 4% paraformaldehyde (PFA), embedded in paraffin wax and sectioned at 6 mm. Sections were re-fixed in 4% PFA then exposed to rabbit IgG primary antibodies to PKCa, bI, bII, g or e (1 : 200; Santa Cruz Biotechnology), anti-PCNA (1 : 100; Santa Cruz Biotechnology) or anti-phosphohistone H3 (1 : 100; Upstate Biotechnology). After washing in PBS, 0.1% BSA, 0.05% Triton X-100, sections were exposed to FITC-linked secondary antibodies (1 : 40; Jackson Immuno Research). Controls included non-specific rabbit IgG [R&D Systems, 1 : 100 dilution in 10% foetal calf serum (FCS) in PBS] in place of primary antibody or pre-absorption of primary antibody with blocking peptides. Both yielded no signal. Labelling indices (number of labelled cells/total cell number Â 100) were obtained from alternate transverse sections through the rostral end of the PNP (i.e. the region of maximal neural fold elevation) stained for PCNA or histone H3. Experiments were carried out in triplicate by an observer blinded to treatment type.
Primary embryonic cell cultures
The trunk distal to the forelimb bud was removed from 15 curly tail embryos (average stage: 27 somites), disrupted mechanically and dissociated by 20 min incubation at room temperature in F10 medium containing 0.12% w/v sodium bicarbonate, 10 mM HEPES, pH 7.4, 1 mg/ml trypsin, 1.5 mg/ml collagenase. After trituration, the suspension was passed through a Nitex filter and centrifuged for 5 min at 1000g. Pelleted cells were resuspended in 5 ml growth medium (Dulbecco's Modified Eagle's Medium, 100 units/ml penicillin, 100 mg/ml streptomycin) containing 10% v/v FCS, then seeded onto tissue culture dishes and cultured at 37 C in 5% CO 2 . For experiments, 10 4 cells (passage 5) were seeded onto glass cover slips coated with poly-L-lysine and fibronectin, cultured for 5 h in growth medium containing 10% FCS, and transferred to growth medium containing 1% FCS for 18 h ('serum starvation'). Cells received either: (i) 100 mM TPA, 10 min prior to fixation in 4% PFA; (ii) 100 mM isoform-specific peptide PKC inhibitor, 20 min prior to fixation, then 100 mM TPA, 10 min prior to fixation; (iii) 50 mg/ ml myo-inositol, 6 h prior to fixation; or (iv) no treatment. For analysis of the effect of inositol, parallel experiments were carried using 3T3 cells. Cells were processed for immunohistochemistry as above and analysed in triplicate by an observer blinded to treatment type.
